Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
OncoTips / Lidiando con el Cáncer / Efectos Secundarios / Complicaciones Orales
OncoLink
Last Modified: September 17, 2012
Dry mouth is most commonly caused by radiation therapy given to the head and neck region of the body. During radiation therapy, saliva production is actually increased due to irritation caused by the radiation or the chemotherapy (if administered). Patients receiving radiation to the head and neck may experience a change in the production and quality of saliva in the major and minor salivary glands. During treatment the saliva tends to be thicker, often described by patients as "ropey" and difficult to mobilize. After treatment, the excessive saliva dissipates and the mouth becomes dry. This can be a temporary side effect, resolving completely or partially over the year after treatment, or result in a permanent loss of saliva production.
Dry mouth may affect speech, taste sensation, ability to swallow, and the use of dentures. Patients may complain of a sore or burning sensation, cracked lips, and fissures in the corners of the lips. There is also an increased risk of cavities, periodontal disease and ultimately, tooth loss due to less saliva. Normal saliva contains enzymes that protect the teeth and gums from bacteria, keeping them healthy.
There are medications and techniques aimed at preventing or reducing xerostomia.
IMRT (intensity modulated radiation therapy)may reduce the extent and permanence of xerostomia. With IMRT, the salivary gland on the side opposite of the cancer receives a lower dose of radiation; therefore salivary function may recover after 6 to 12 months following the completion of treatment. This is dependent upon the dose as well as the percentage of the salivary gland that receives radiation therapy.
Amifostine, a radiation protector of normal tissues, has been shown to protect the salivary glands when given daily with radiation therapy, although logistics and side effects have limited its use in practice. Furthermore, it is not clear what benefit Amifostine adds when modern radiation techniques such as IMRT are utilized since treatment with Intensity Modulated Radiation Therapy (IMRT) or Proton therapy may allow the radiation oncologist to spare the salivary glands from getting significant radiation dose. This may prevent dry mouth in the future. There is also some concern that Amofostine may be a radioprotectant. Meaning it may protect the tissues in the treatment area from the radiation, meaning the cancer cells would not receive the treatment.
If you are getting radiation therapy to the head and neck region, you should discuss these options with your radiation oncologist.
If you have developed xerostomia, there are management strategies that can effectively deal with your dry mouth and prevent cavities and periodontal disease. Try to follow these simple guidelines:
Ms. Hollis discusses the role of the nurse practitioner in oncology care. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

